.
MergerLinks Header Logo

New Deal


Announced

Completed

Mountaingate Capital-backed BioDerm completed the acquisition of Argentum Medical from Shore Capital Partners.

Synopsis

Mountaingate Capital-backed BioDerm, a manufacturer of proprietary hydrocolloid products, completed the acquisition of Argentum Medical, a provider of infection prevention solutions and wound care products, from Shore Capital Partners, a Chicago-based private equity firm. Financial terms were not disclosed. "Shore Capital is immensely proud of what Raul and the management team built. We are excited for Argentum to continue providing significant value to the healthcare system as an international industry leader in infection prevention management," Don Pierce, Shore Partner.

Show Details & Financials

Market Context

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US